GMP ORPHAN DRUGS FOR ORPHAN DISEASES

Dead / Cancelled — Cancelled — Section 71 (as of 06 Mar 2026)

What this means for you

This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
79134010
Registration number
4541221
Mark type
Design + words
Filed
14 May 2013
Published for opposition
18 Mar 2014
Registered
03 Jun 2014
Attorney of record
Heather Smith-Carra

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical and veterinary products for the treatment of orphan diseases; medication for the treatment of orphan diseases; pharmaceutical and veterinary products for pediatric use for the treatment of orphan diseases; medication for pediatric use for the treatment of orphan diseases; chemical preparations for medical or pharmaceutical use in the treatment of childhood diseases; pharmaceutical and veterinary products and medicines for the treatment of orphan diseases, particularly spinal muscular atrophy, sickle-cell anemia, progressive nuclear palsy, amyotrophic lateral sclerosis (ALS), cystic fibrosis, Duchenne muscular dystrophy, macrophagic myofasciitis, lysosomal storage disease, leukodystrophy; pharmaceutical and veterinary products and medicines for the treatment of hyperammonemia of all kinds
  • Class 010 — Medical apparatus: [ Medical, surgical and veterinary apparatus and instruments, for diagnosis and treatment, particularly in connection with orphan diseases; medical devices containing chemical products for diagnostic use of orphan diseases; medical diagnosis apparatus and instruments to diagnose orphan diseases; automatic testing apparatus to diagnose orphan diseases, for medical use, also in the form of kits; medical apparatus and instruments in the form of kits for detecting the presence of analytes in biological fluids, other fluids and other structures; immunochemical testing apparatus for medical use; blood testing apparatus; radiological apparatus for medical use; resuscitation apparatus; medical imaging apparatus incorporating medical imaging software; needles for medical use; gloves for medical use; syringes for medical use; inhalers for medical purposes; injectors for medical use; X-ray photographs for medical use; radiology screens for medical use; receptacles for applying medicines; containers especially made for medical waste; probes for medical use; stethoscopes; heart pacemakers; thermometers for medical use; cases fitted for medical instruments for use by surgeons or doctors ]
  • Class 042 — Scientific and technological services: Evaluations, assessments and research in the fields of science; research and development services in the field of medicine; research and development of new products for others, namely, medical diagnosis apparatus; research and development in the field of biotechnology; scientific research for medical purposes; scientific laboratory services in the medical field; all the aforesaid services in connection with the treatment of childhood and orphan diseases, particularly spinal muscular atrophy, sickle-cell anemia, progressive nuclear palsy, amyotrophic lateral sclerosis (ALS), cystic fibrosis, Duchenne muscular dystrophy, macrophagic myofasciitis, lysosomal storage disease, leukodystrophy
  • Class 044 — Medical, beauty and agricultural services: Medical services; medical and sanitary care, namely, telemedecine services including remote diagnosis or medical follow-up; medical testing for the diagnosis and treatment of persons; providing medical advice on health matters in the field of medication administration; providing medical advisory services relating to medical apparatus and instruments; medical diagnosis services of orphan diseases; providing medical information, all the aforesaid services in connection with the treatment of childhood and orphan diseases, particularly spinal muscular atrophy, sickle-cell anemia, progressive nuclear palsy, amyotrophic lateral sclerosis (ALS), cystic fibrosis, Duchenne muscular dystrophy, macrophagic myofasciitis, lysosomal storage disease, leukodystrophy

Owner

Prosecution history

  • 06 Mar 2026 — CANCELLED SECTION 71
  • 09 Jun 2023 — INTERNATIONAL REGISTRATION RENEWED
  • 03 Jun 2023 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
  • 05 Dec 2021 — PARTIAL INVALIDATION PROCESSED BY THE IB
  • 27 Oct 2021 — PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
  • 27 Oct 2021 — INVALIDATION PROCESSED
  • 06 Oct 2021 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
  • 06 Feb 2021 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
  • 06 Feb 2021 — REGISTERED - PARTIAL SEC 71 ACCEPTED
  • 01 Feb 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 29 Jan 2021 — CHANGE OF NAME/ADDRESS REC'D FROM IB
  • 03 Dec 2020 — TEAS SECTION 71 RECEIVED
  • 03 Jun 2019 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
  • 07 Feb 2019 — NEW REPRESENTATIVE AT IB RECEIVED
  • 08 Feb 2018 — CHANGE OF NAME/ADDRESS REC'D FROM IB

View this trademark record on Rightsy